Mauna Kea Technologies is looking to raise up to $67 million through an initial public offering of 3.29 million shares on the NYSE Euronext stock exchange.
The offering will priced between 10.65 euros and 13 euros a share and is expected to close on July 4, according to Reuters news service .
The funding will go towards sales support of the Cellvisio platform, a probe-based laser microscope that can examine the inside of any part of the human body in real time. The company was founded in 2000 and received the CE Mark and FDA approval for use in the gastrointestinal tract and lungs in 2005.
The company is conducting clinical trials to evaluate Cellvisio for use in indications other than gastrointestinal and lung applications.
Here’s a roundup of other dealflow and investment news:
- Merge Healthcare completes $52 private offering
Merge Healthcare Inc. (NASDAQ:MRGE) closed a private offering of $52 million in aggregate principal of its 11.75 percent senior secured notes, which are due 2015. The company plans to use the proceeds to pay off outstanding preferred stock from a Series A round.
- Vermillion joins Russell Microcap
Vermillion Inc. (NYSE:VRML) announced that it will be listed in the Russell Microcap Index, which represents the lower third of the 3,000 largest companies representing 98 percent of the investable equity in the U.S. market. Russell indices are often used by investment managers and institutional investors as a benchmark for active and passive investment.
- CASMED lands $15 million in private placement
CAS Medical Systems Inc. (NSDQ:CASM) announced that it closed a $15 million private placement funding round for a combination of convertible preferred stock and non-voting exchangeable preferred stock with Thomas, McNerney & Partners. The Branford, Conn.-based company plans to use the funding to advance operating and growth for its Fore-sight tissue oximeter, which won FDA clearance in January, as well as other monitoring products.
- Universal Hospital Services completes $175 million offering
Universal Hospital Services Inc. announced that it closed its offering of $175 million second lien PIK notes due 2015. The medical equipment management solutions provider plans to use the funds to repay revolving borrowings under its credit facility, pay fees and expenses related to the offering, pay a cash distribution to equity holders and for general corporate purposes, according to the release.
- Jan Medical raises $3.15 million in Series A round
Jan Medical, maker of portable brain sensing systems, announced that it landed $3.15 million in a Series A funding round lead by Germany-based Brainlab. The Mountain View, Calif.-based company plans to use the funds to advance clinical trials and file for FDA 510(k) for its mobile brain sensor.
- Guided Therapeutics wins $500,000 federal grant
Guided Therapeutics Inc. (OTC:GTHP) landed a $500,000 grant from the Dept. of Health & Human Services’ Small Business Innovation Research Program for the company’s Instacortisol study assessing real-time and continuous levels of cortisol in interstitial fluid.